2. Membrane Transporter/Ion Channel
  3. Sodium Channel
  4. Recainam hydrochloride

Recainam hydrochloride  (Synonyms: Wy-42362 hydrochloride)

Cat. No.: HY-105454A
Handling Instructions Technical Support

Recainam (Wy-42362) hydrochloride is a potent orally active antiarrhythmic agent and a sodium channel inhibitor. Recainam hydrochloride elevates ventricular fibrillation threshold, suppresses induced cardiac dysrhythmias, and may accentuate cardiac tissue refractoriness heterogeneity. Recainam hydrochloride can be used for the research of arrhythmias.

For research use only. We do not sell to patients.

Recainam hydrochloride

Recainam hydrochloride Chemical Structure

CAS No. : 74752-07-1

Size Stock
50 mg   Get quote  
100 mg   Get quote  
250 mg   Get quote  

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

Other In-stock Forms of Recainam hydrochloride:

Other Forms of Recainam hydrochloride:

Recainam hydrochloride Related Antibodies

Top Publications Citing Use of Products

View All Sodium Channel Isoform Specific Products:

View All Isoforms
Nav1.1 Nav1.2 Nav1.3 Nav1.4 Nav1.5 Nav1.6 Nav1.7 Nav1.8 Nav1.9

  • Biological Activity

  • Purity & Documentation

  • References

  • Customer Review

Description

Recainam (Wy-42362) hydrochloride is a potent orally active antiarrhythmic agent and a sodium channel inhibitor. Recainam hydrochloride elevates ventricular fibrillation threshold, suppresses induced cardiac dysrhythmias, and may accentuate cardiac tissue refractoriness heterogeneity. Recainam hydrochloride can be used for the research of arrhythmias[1][2][3][4].

In Vitro

Recainam (10-300 μM; ≥30 min) hydrochloride has no significant effect on key electrophysiologic variables of isolated rabbit sinoatrial node preparations, aside from modestly shortening action potential duration[2].
Recainam (10-100 μM; ≥30 min) hydrochloride significantly reduces the maximal rate of rise of phase 0 (V̇max) in isolated rabbit atrial muscle preparations without altering other key electrophysiologic variables[2].
Recainam (10-300 μM; ≥30 min) hydrochloride causes concentration-dependent reductions in the maximal rate of rise of phase 0 (V̇max) in isolated canine ventricular muscle preparations without altering action potential duration or effective refractory period[2].
Recainam (1-300 μM; ≥30 min) hydrochloride causes concentration-dependent reductions in the maximal rate of rise of phase 0 (V̇max), action potential amplitude, action potential duration, and effective refractory period in isolated canine Purkinje fiber preparations[2].
Recainam (10-60 μM; ≥30 min) hydrochloride shifts the membrane responsiveness curve in the hyperpolarizing direction in isolated canine Purkinje fiber preparations, with higher concentrations abolishing premature responses from depolarized membrane potentials[2].
Recainam (300 μM; ≥30 min) hydrochloride induces a frequency-dependent reduction in the maximal rate of rise of phase 0 (V̇max) in isolated canine Purkinje fiber, canine ventricular muscle, and rabbit atrial muscle preparations, and abolishes responses at frequencies >3 Hz in Purkinje fibers[2].
Recainam (100 μM; ≥10 min) hydrochloride depresses phase 4 depolarization and slows isoproterenol-induced automaticity in isolated canine Purkinje fiber preparations[2].
Recainam (300 μM; ≥30 min) hydrochloride does not affect slow channel-dependent potentials induced by high potassium and isoproterenol in isolated canine ventricular muscle and Purkinje fiber preparations[2].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Recainam hydrochloride Related Antibodies
Parmacokinetics
Species Dose Route AUC0-∞ T1/2 MRT Vss Cmax Bioavailability Tmax
Dog[3] 15 mg/kg i.v. 20.9 μg·h/mL 1.8 h 2.3 h 1.2 L/kg / / /
Dog[3] 15 mg/kg p.o. 18.1 μg·h/mL / / / 8.5 μg/mL 89 % 2.0 h
Mice[3] 100 mg/kg p.o. 16.6 μg·h/mL 0.8 h / / 13.5 μg/mL / /
Mice[3] 120 mg/kg p.o. 26.9 μg·h/mL 1.2 h / / 23.5 μg/mL / /
Mice[3] 208 mg/kg p.o. 64.3 μg·h/mL 1.0 h / / 48.7 μg/mL / /
Mice[3] 54 mg/kg p.o. / / / / 6.4 μg/mL / /
Rabbit[3] 100 mg/kg p.o. 39.6 μg·h/mL 3.4 h / / 16.0 μg/mL / /
Rabbit[3] 25 mg/kg i.v. 5.0 μg·h/mL 0.6 h 0.7 h 3.6 L/kg / / /
Rabbit[3] 50 mg/kg p.o. / / / / 4.1 μg/mL / /
Rat[3] 100 mg/kg p.o. 10.5 μg·h/mL 3.1 h / / 1.3 μg/mL 51 % /
Rat[3] 110 mg/kg p.o. 19.9 μg·h/mL 4.5 h / / 6.6 μg/mL / /
Rat[3] 20 mg/kg i.v. 4.1 μg·h/mL 0.6 h 0.6 h 3.2 L/kg / / /
Rat[3] 500 mg/kg p.o. 73.9 μg·h/mL 3.6 h / / 7.8 μg/mL / /
Rhesus monkey[3] 15 mg/kg i.v. 12.8 μg·h/mL 1.6 h 1.9 h 2.2 L/kg / / /
Rhesus monkey[3] 15 mg/kg p.o. 12.0 μg·h/mL 1.9 h / / 3.3 μg/mL 97 % /
In Vivo

Recainam (3.75-7.5 mg/kg loading; 0.0375-0.075 mg/kg per min maintenance; i.v.; loading dose over 20 min; maintenance infusion for remainder of experiment) hydrochloride elevates the energy required for ventricular defibrillation in a dose-dependent manner, with low and high doses increasing E50 by 42% and 92%, respectively, while prolonging QRS duration without altering ventricular effective refractory period[1].
Recainam (p.o.; i.v.) hydrochloride exhibits anti-arrhythmic activity in dogs with experimentally induced cardiac arrhythmias[3].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: Mongrel dogs (male, 14-23 kg, anesthetized with sodium pentobarbital)[1]
Dosage: 3.75 mg/kg (loading) + 0.0375 mg/kg per min (maintenance); 7.5 mg/kg (loading) + 0.075 mg/kg per min (maintenance)
Administration: i.v.; loading dose over 20 min; maintenance infusion for remainder of experiment
Result: Increased sinus QRS duration by 11% and paced QRS duration by 14% at low dose.
Produced no significant change in ventricular effective refractory period or sinus cycle length at low dose.
Increased E50 by 42% at low dose.
Increased sinus QRS duration by 27% and paced QRS duration by 23% at high dose.
Produced no significant change in ventricular effective refractory period or sinus cycle length at high dose.
Increased E50 by 92% at high dose.
Caused changes in E50 that were significantly different from the saline group and between low and high dose groups.
Showed no statistically significant difference in percent change of sinus QRS duration between low and high dose groups.
Molecular Weight

299.84

Formula

C15H26ClN3O
CAS No.
SMILES

CC(C)NCCCNC(NC1=C(C=CC=C1C)C)=O.[H]Cl
Shipping

Room temperature in continental US; may vary elsewhere.
Storage

Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
  • No file chosen (Maximum size is: 1024 Kb)
  • If you have published this work, please enter the PubMed ID.
  • Your name will appear on the site.

Recainam hydrochloride Related Classifications

  • Molarity Calculator

  • Dilution Calculator

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass   Concentration   Volume   Molecular Weight *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Keywords:

Recainam74752-07-1Wy-42362Wy42362Wy 42362Sodium ChannelNa channelsNa+ channelsventricular musclecardiac arrhythmiasPurkinje fiberspremature ventricular complexessodium channelventricular arrhythmiassinoatrial nodeatrial muscleventricular ectopic beatscanineInhibitorinhibitorinhibit

Your Recently Viewed Products:

Inquiry Online

Your information is safe with us. * Required Fields.

Product Name

  

Requested Quantity *

Applicant Name *

 

Salutation

Email Address *

 

Phone Number *

Department

 

Organization Name *

City

State

Country or Region *

      

Remarks

Bulk Inquiry

Inquiry Information

Product Name:
Recainam hydrochloride
Cat. No.:
HY-105454A
Quantity:
MCE Japan Authorized Agent:

Customer Review

Thank You for Your Feedback!

Request for HNMR Report

Please fill out this form to request the QC report. We will send it to your Email address shortly.

Your information is safe with us. * Required Fields.

Product Name

  

Lot #

Applicant Name *

 

Email Address *

Phone Number

 

Department *

Organization Name *

 

Country or Region *

Remarks

SAFETY DATA SHEET (SDS)

Request for HNMR Report

We have received your request and will respond to you as soon as possible.